Mahatme Sandesh Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$155,500.00
Insider Sells Quantity
7
Insider Sells Sum
$72.88M

Insider Activity of Mahatme Sandesh

Biography of Mahatme Sandesh

No biography is available at this moment.

2019-12-13SaleSarepta Therapeutics, Inc.
SRPT
EVP, CFO & CBO
125,000
0.1554%
$125.50$15.69M+4.3%
2019-02-07SaleSarepta Therapeutics, Inc.
SRPT
EVP, CFO & CBO
130,000
0.1113%
$84.42$10.98M-12.1%
2019-01-31SaleSarepta Therapeutics, Inc.
SRPT
EVP, CFO & CBO
42,396
0.0553%
$130.72$5.54M-13.43%
2019-01-30SaleSarepta Therapeutics, Inc.
SRPT
EVP, CFO & CBO
87,604
0.1222%
$130.00$11.39M-6.79%
2018-10-24SaleSarepta Therapeutics, Inc.
SRPT
EVP, CFO & CBO
215,048
0.337%
$127.74$27.47M-1.35%
2017-07-20SaleSarepta Therapeutics, Inc.
SRPT
EVP, CFO & CBO
7,627
0.0124%
$41.00$312,707+46.25%
2016-10-17SaleSarepta Therapeutics, Inc.
SRPT
Senior Vice President, CFO
30,000
0.0562%
$50.08$1.5M-29.97%
2013-08-20PurchaseSarepta Therapeutics, Inc.
SRPT
Senior Vice President, CFO
5,000
0.0142%
$31.10$155,500-13.53%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.